Ana sayfa
Piyasalar
Grafikler ve fikirler
Algo
Haberler
Store
Aracı kurumlar
İndir
Ekonomik Takvim
Alım-satım sinyalleri
Web Terminali
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
GALT
#3040
Galectin Therapeutics Inc.
2.9
8
-1.32%
Sektör:
Baz:
Kar para birimi:
Günlük aralık
Yıllık aralık
Günlük değişim
-1.32%
Aylık değişim
-5.40%
6 aylık değişim
-25.87%
Yıllık değişim
+104.11%
Önceki kapanış
3.0
2
Open
2.9
8
Bid
Ask
Low
2.9
8
High
2.9
8
Hacim
21
Piyasalar
ABD hisse senetleri
Sağlık hizmetleri
GALT
Open full chart
Financials
Overview
Rapor
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
62.76 M
63.18 M
63.29 M
64.06 M
64.47 M
—
Valuation ratios
Enterprise value
146.04 M
66.88 M
70.28 M
121.89 M
262.01 M
521.06 M
Price to earnings ratio
-3.77
-1.7
-1.69
-3.3
-7.18
-13.87
Price to sales ratio
455.96
136.7
-299.01
183.93
124.5
146.11
Price to cash flow ratio
-5.05
-1.92
-2.04
-3.71
-8.7
-16.37
Price to book ratio
-0.54
-0.76
-0.19
-0.31
-0.58
-1.84
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.39
0.68
1.01
0.48
0.64
2.81
Return on equity %
0.12
0.11
0.08
0.06
0.07
0.33
Return on invested capital %
—
—
—
—
—
—
Gross margin %
100
100
100
100
100
400
Operating margin %
1 203.98
-1 087.31
31.59 K
421.99
190.39
31.11 K
EBITDA margin %
—
—
—
—
—
—
Net margin %
1 490.04
-1 046.98
38.52 K
686.22
371.16
38.53 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
1.13
0.49
0.08
1.43
0.09
2.1
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.03
-0.05
0
0.09
0.15
0.19
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
0.14
0.21
0.12
0.1
0.05
0.49
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
0.43
0.24
0.12
0.22
0.18
0.76
Net current asset value per share
0.46
0.28
0.15
0.24
0.2
0.87
Tangible book value per share
1.5
1.67
1.8
1.87
1.94
7.28
Working capital per share
0.05
-0.29
-1.61
0.07
-1.93
-3.75
Book value per share
1.5
1.67
1.8
1.87
1.94
7.28
Haberler
Galectin Therapeutics yönetim kurulu üyesi Marc Rubin istifa etti
Galectin Therapeutics director Marc Rubin resigns from board
Galectin Therapeutics CFO’su 233 bin dolarlık hisse satışı gerçekleştirdi
Galectin Therapeutics CFO sells $233k in shares
Galectin Therapeutics: Runway With Convertible Financing But Dilution Overhang Remains
oracle, micron tech among market cap stock movers on friday
Galectin Therapeutics hisseleri FDA geri bildirimi sonrası sert düşüş yaşadı
Galectin Therapeutics stock plummets after FDA feedback on drug
FDA, Galectin’in belapectin geliştirme programı hakkında geri bildirim verdi
FDA provides feedback on Galectin’s belapectin development program
Galectin Therapeutics yöneticisi 1,05 milyon dolar değerinde hisse sattı
Galectin Therapeutics hissedarları yönetim kurulu üyelerini seçti ve önemli teklifleri onayladı